OptiLIGHT for Chalazion

Not yet recruiting at 1 trial location
HH
Overseen ByHaya Hamza, Bsc
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

To study the effectiveness and safety of IPL treatment for Chalazion

Who Is on the Research Team?

JC

James Chelnis, MD

Principal Investigator

Manhattan Face and Eye clinic

LP

Laura Periman

Principal Investigator

Periman Eye Institute

Are You a Good Fit for This Trial?

This trial is for adults who can understand and sign a consent form, have been diagnosed with an inflamed chalazion in the left eye, and are willing to follow all study procedures. Specific details on who cannot participate were not provided.

Inclusion Criteria

I have been diagnosed with an inflamed chalazion.
* Subject is able to read, understand, and sign an Informed Consent Form (ICF)
* Subject is willing to comply with all study procedures-
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Intense Pulsed Light (IPL) treatment or sham IPL treatment for chalazion

4 weeks
Weekly visits for treatment

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
1 visit (in-person) at the end of follow-up

What Are the Treatments Tested in This Trial?

Interventions

  • OptiLIGHT

Trial Overview

The trial is evaluating the effectiveness and safety of using Intense Pulsed Light (IPL) treatment, known as OptiLIGHT, specifically for treating chalazions in the inflammatory stage.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: study armExperimental Treatment1 Intervention
Group II: Control armPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Lumenis Be Ltd.

Lead Sponsor

Trials
39
Recruited
1,500+